CLINICAL TRIALS PROFILE FOR ERYPED

All Clinical Trials for ERYPED

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02757534 ↗	Domperidone for Chronic Nausea and Vomiting	No longer available	Assouline-Dayan, Yehudith		1969-12-31	The purpose of this study is to provide oral domperidone to patients with gastroparesis, between the ages of 18 and 60 years of age, who have failed standard treatment. Standard therapy at the University of Iowa is eating blended foods, liquid diet, Eryped syrup (125 mg TID) 30 minutes before meals, or reglan (20 mg BID).
NCT02757534 ↗	Domperidone for Chronic Nausea and Vomiting	No longer available	Yehudith Assouline-Dayan		1969-12-31	The purpose of this study is to provide oral domperidone to patients with gastroparesis, between the ages of 18 and 60 years of age, who have failed standard treatment. Standard therapy at the University of Iowa is eating blended foods, liquid diet, Eryped syrup (125 mg TID) 30 minutes before meals, or reglan (20 mg BID).

Clinical Trial Conditions for ERYPED

Condition Name

Condition Name for ERYPED
Intervention	Trials
Gastroparesis	1

Condition MeSH

Condition MeSH for ERYPED
Intervention	Trials
Vomiting	1
Gastroparesis	1

Clinical Trial Locations for ERYPED

Trials by Country

Trials by Country for ERYPED
Location	Trials
United States	1

Trials by US State

Trials by US State for ERYPED
Location	Trials
Iowa	1

Clinical Trial Progress for ERYPED

Clinical Trial Phase

Clinical Trial Phase for ERYPED
Clinical Trial Phase	Trials

Clinical Trial Status

Clinical Trial Status for ERYPED
Clinical Trial Phase	Trials
No longer available	1

Clinical Trial Sponsors for ERYPED

Sponsor Name

Sponsor Name for ERYPED
Sponsor	Trials
Assouline-Dayan, Yehudith	1
Yehudith Assouline-Dayan	1

Sponsor Type

Sponsor Type for ERYPED
Sponsor	Trials
Other	2